Zhenggang Bai1, Shiga Luo2, Luyao Zhang2, Sijie Wu2, Iris Chi3. 1. Evidence-Based Research Center of Social Science & Health, Public Affair School of Nanjing University of Science & Technology, Nanjing 210000, China. Electronic address: 363212810@qq.com. 2. Evidence-Based Research Center of Social Science & Health, Public Affair School of Nanjing University of Science & Technology, Nanjing 210000, China. 3. Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles, USA.
Abstract
OBJECTIVES: The aim of this study is to investigate the effectiveness of ACT on depression reduction and further examine the relationship between different follow-up periods, different degree of depression, and different age of patients through subgroup analysis. METHODS: Relevant electronic databases were searched from Jan 2010 to Aug 2018, including CNKI, WANFANG, PubMed, EMBASE, Cochrane Library, PsycINFO. Two reviewers independently screened for eligible studies, extracted data, and assessed risk of bias of the included studies. The Cochrane Collaboration's bias assessment tool was used to evaluate the risk of bias for included studies, and Review Manager 5.3 Software for the meta-analysis RESULTS: 18 studies with 1,088 participants were included in the review. Four studies were rated as high-quality studies, and the remaining 14 studies were rated as moderate quality studies. ACT significantly reduced depression as compared with the control group [SMD = 0.59, 95% CI (0.38, 0.81)]. The subgroup analysis found a significant difference between ACT and control group after post-intervention, three months follow up, mild depression group and adults group, [SMD= 0.62, 95% CI (0.35, 0.90), [SMD= 0.55, 95% CI (0.23, 0.87)], [SMD= 0.65, 95% CI (0.40, 0.91)], [SMD= 0.52, 95% CI (0.33, 0.71)] respectively. LIMITATIONS: The heterogeneity between included studies results in heterogeneity of the results. Most of the specific methods for random sequence generation and allocation concealment were not clear. The search results had limitations since only the published studies in Chinese and English were searched and lacked a search for gray and paper documents. CONCLUSIONS: The current study suggested that ACT was significantly for reducing depressive symptoms compared with the control group, especially at three months of follow-up, adult group and mild depression. More research is needed to investigate the difference effects for minor group, moderate and severe depression and long-term follow-up.
OBJECTIVES: The aim of this study is to investigate the effectiveness of ACT on depression reduction and further examine the relationship between different follow-up periods, different degree of depression, and different age of patients through subgroup analysis. METHODS: Relevant electronic databases were searched from Jan 2010 to Aug 2018, including CNKI, WANFANG, PubMed, EMBASE, Cochrane Library, PsycINFO. Two reviewers independently screened for eligible studies, extracted data, and assessed risk of bias of the included studies. The Cochrane Collaboration's bias assessment tool was used to evaluate the risk of bias for included studies, and Review Manager 5.3 Software for the meta-analysis RESULTS: 18 studies with 1,088 participants were included in the review. Four studies were rated as high-quality studies, and the remaining 14 studies were rated as moderate quality studies. ACT significantly reduced depression as compared with the control group [SMD = 0.59, 95% CI (0.38, 0.81)]. The subgroup analysis found a significant difference between ACT and control group after post-intervention, three months follow up, mild depression group and adults group, [SMD= 0.62, 95% CI (0.35, 0.90), [SMD= 0.55, 95% CI (0.23, 0.87)], [SMD= 0.65, 95% CI (0.40, 0.91)], [SMD= 0.52, 95% CI (0.33, 0.71)] respectively. LIMITATIONS: The heterogeneity between included studies results in heterogeneity of the results. Most of the specific methods for random sequence generation and allocation concealment were not clear. The search results had limitations since only the published studies in Chinese and English were searched and lacked a search for gray and paper documents. CONCLUSIONS: The current study suggested that ACT was significantly for reducing depressive symptoms compared with the control group, especially at three months of follow-up, adult group and mild depression. More research is needed to investigate the difference effects for minor group, moderate and severe depression and long-term follow-up.
Authors: Roberto López; Lia Follet; Annamarie B Defayette; Emma D Whitmyre; Jennifer Wolff; Anthony Spirito; Christianne Esposito-Smythers Journal: J Clin Psychol Date: 2021-08-10
Authors: Amy S Grinberg; Rachel D Best; Kathryn M Min; Emmanuelle A D Schindler; Brian B Koo; Jason J Sico; Elizabeth K Seng Journal: Curr Pain Headache Rep Date: 2021-10-19
Authors: Ivan Aprahamian; Marcus K Borges; Denise J C Hanssen; Hans W Jeuring; Richard C Oude Voshaar Journal: Clin Interv Aging Date: 2022-06-22 Impact factor: 3.829
Authors: Sarah C Griffin; Jonathan R Young; Jennifer C Naylor; Kelli D Allen; Jean C Beckham; Patrick S Calhoun Journal: Pain Med Date: 2022-02-01 Impact factor: 3.637
Authors: Mario Maj; Dan J Stein; Gordon Parker; Mark Zimmerman; Giovanni A Fava; Marc De Hert; Koen Demyttenaere; Roger S McIntyre; Thomas Widiger; Hans-Ulrich Wittchen Journal: World Psychiatry Date: 2020-10 Impact factor: 49.548
Authors: Eirini Karyotaki; Marit Sijbrandij; Marianna Purgato; Ceren Acarturk; Daniel Lakin; Della Bailey; Emily Peckham; Ersin Uygun; Federico Tedeschi; Johannes Wancata; Jura Augustinavicius; Ken Carswell; Maritta Välimäki; Mark van Ommeren; Markus Koesters; Mariana Popa; Marx Ronald Leku; Minna Anttila; Rachel Churchill; Ross White; Sarah Al-Hashimi; Tella Lantta; Teresa Au; Thomas Klein; Wietse A Tol; Pim Cuijpers; Corrado Barbui Journal: Eur J Psychotraumatol Date: 2021-07-05